Clinical Applications of Nanotechnology and AI Integration

1. Auflage 2026
ISBN: 978-1-032-52282-1
Verlag: Taylor & Francis Ltd

Buch, Englisch, 464 Seiten, Format (B × H): 178 mm x 254 mm, Gewicht: 453 g

The convergence of nanomedicine and artificial intelligence (AI) is revolutionizing healthcare, offering unprecedented advancements in diagnostics, drug delivery, and personalized treatment. Nanomedicine and AI-Enabled Technology in Clinical Application provides an in-depth exploration of these transformative fields, shedding light on cutting-edge innovations and their real-world clinical implications.

• The role of nanotechnology in targeted drug delivery, regenerative medicine, and disease treatment.
• How AI-driven models are optimizing diagnostics, predicting disease progression, and personalizing therapies.
• The challenges and ethical considerations of nanoparticles in biological systems and their long-term impact.
• Sustainable and green nanotechnology approaches for safer and more effective medical applications.

Edited by leading experts, this book serves as a valuable resource for researchers, clinicians, medical professionals, and industry leaders striving to harness the potential of nanomedicine and AI for improved global healthcare. As we stand on the brink of a new medical era, this book offers the insights needed to navigate the future of precision medicine and technological innovation.
Are you ready to explore the future of medicine? Dive into this book to discover how AI and nanotechnology are reshaping the healthcare landscape!

Zielgruppe

Academic, Postgraduate, Professional Practice & Development, and Undergraduate Advanced

Autoren/Hrsg.

B. Luu, Brent

Feng, Xiaodong

Yang, Catherine

Fachgebiete

• Technische Wissenschaften Verfahrenstechnik | Chemieingenieurwesen | Biotechnologie Biotechnologie Medizinische Biotechnologie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Pharmakologie, Toxikologie
• Technische Wissenschaften Verfahrenstechnik | Chemieingenieurwesen | Biotechnologie Lebensmitteltechnologie und Getränketechnologie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Pharmazie

Inhaltsverzeichnis

Preface. 1: An Introduction to Nanotechnology and Its Applications. 2: Drug Delivery and Nanoparticles. 3: Future Perspectives in Nanotechnology. 4: Laws and Regulations of Nanotechnology in Drug Therapy. 5: 3D Printing of Microneedles. 6: 3D Printing and Nano Application. 7: Clinical Implementation of Nanotechnology in Cancer. 8: Gene Delivery using Nanovectors. 9: Nanotechnology in Treatment of Bacterial Infections. 10: Nanotechnology in Viral Control. 11: NANOTECHNOLGY IN EMERGENCY MEDICINE. 12: Advancing Cancer Treatment: The Promise of Nanotechnology-Enhanced Therapeutics.13: Application of Nanotechnology in Treatments of Food Allergy. 14: Nanotechnology in Neurological Disorders and Treatment. 15: Nanotechnology in Surgery. 16: The Clinical Applications of Nanotechnology in Cardiology. 17: Use of Nanotechnology in Pain Management. 18: The Application of Nanotechnology in Chronic Diseases. 19: Nanotechnology on Clinical Detection of Cancer Biomarkers. 20: Harnessing Nanoparticles for Cancer Immunotherapy: Enhancing Treatment Outcomes. 21: Innovative Nanomedicine: Characterization and Analysis of Nanoparticles in Clinical Trials. 22: AI in Nanotech Pharmacology: Revolutionizing Drug Development. 23: Artificial-Intelligence in Drug Design and Clinical Trials. 24: Advances in Nanotechnology and Imaging for Image-Guided Surgery. 25: Integrating Nanotechnology and Artificial Intelligence in Stroke Management. 26: Artificial Intelligence in Imaging Diagnostics. Index

Über Autor(innen)

Catherine Yang, PhD, MD (h.c.)

Vice President of Academic Affairs & Research, Dean, College of Graduate Studies, and Professor of Molecular Pharmacology, Medicinal Chemistry, and Biomedical Sciences

Dr. Catherine F. Yang earned her Master’s and PhD in Medicinal Chemistry from Tufts University, followed by postdoctoral training in Molecular Pharmacology, Clinical Biochemistry, and Oncology at Harvard Medical School.

Currently, Dr. Yang is a Professor of Molecular Pharmacology and Clinical Biochemistry in the Department of Basic Science at the College of Medicine and College of Graduate Studies at California Northstate University (CNU). Before joining CNU in 2016, she was a Professor of Biochemistry and Pharmacology at Rowan University, holding faculty appointments at its Cooper Medical School and the Department of Chemistry & Biochemistry. She has also held research and faculty positions at Harvard Medical School, the American Health Foundation, Boston Biomedical Research Institute, Tokyo University of Medicine and Dentistry, the University of Pennsylvania, Zhejiang University, and Zhejiang University of Technology.

With over 25 years of teaching experience, Dr. Yang specializes in medicinal chemistry, molecular pharmacology, and clinical biochemistry. Her research has significantly contributed to understanding tumor progression, developing novel cancer drugs, type 2 diabetes treatments, and allergy vaccines. She has led research teams investigating proteolytic regulatory mechanisms in advanced prostate cancer, lung cancer, and leukemia. Her work on type 2 diabetes metabolic regulation resulted in a patente